The Core Idea
A randomized controlled trial (RCT) tests whether something — a supplement, a drug, a diet — actually *causes* an effect. Participants are split at random into a group that gets the intervention and a group that gets a comparison, such as a placebo or usual care. Because assignment is random, the groups should be similar in every way except the one thing being tested.
Why Randomization Matters
Random assignment balances both known and unknown differences between groups — age, diet, motivation, and a hundred things researchers can't measure. That balance is what lets an RCT separate the effect of the intervention from confounding, the problem that undermines most observational studies (see Observational Studies vs RCTs).
Blinding and Placebos
- Single-blind: participants don't know which group they're in.
- Double-blind: neither participants nor the researchers measuring outcomes know.
Blinding keeps expectations from coloring the results. A placebo — an inert look-alike — gives a fair comparison, because simply believing you're receiving something can change how you feel.
Limitations
RCTs are powerful but not perfect:
- They're often expensive and short, so they may miss long-term effects.
- They often enroll narrow populations, so results may not apply to everyone.
- Tightly controlled conditions may not reflect messy real life.
- Some questions can't be tested in an RCT for practical or ethical reasons.
Where RCTs Sit
A single well-run RCT is strong evidence; several RCTs pooled in a meta-analysis are stronger still. The U.S. National Library of Medicine and NCCIH both offer plain-language guides for building these reading skills [1][2].